Supported by Grant NIH/NEI K23-EY022947-01A1 (JPE), Ohio Department of Development TECH-13-059 (JPE, SKS), Research to Prevent Blindness (Cole Eye Institutional), and Thrombogenics THROM1403JE (JPE).
Disclosure: J.P. Ehlers, Bioptigen (C), Thrombogenics (C, R), Genentech (R), Leica (C), Zeiss (C), Alcon (C), P; J. Han, None; D. Petkovsek, None; P.K. Kaiser, Zeiss (C), Topcon (C), Alcon (C), Novartis (C), Bausch and Lomb (C); R.P. Singh, Zeiss (C); S.K. Srivastava, Bausch and Lomb (C, R); Allergan (R); Leica (C), Carl Zeiss Meditec (C), P